Corrigendum to ‘Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC‐HF baseline characteristics and comparison with contemporary clinical trials’ [Eur J Heart Fail 2020;11:2160–2171]
Gespeichert in:
Veröffentlicht in: | European journal of heart failure 2022-03, Vol.24 (3), p.591-591 |
---|---|
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 591 |
---|---|
container_issue | 3 |
container_start_page | 591 |
container_title | European journal of heart failure |
container_volume | 24 |
description | |
doi_str_mv | 10.1002/ejhf.2404 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9050114</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2612387141</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2204-e9593633efc3532ff38856322b2f0f6d4c9e57465d0c77dcfbdf2950875bb3063</originalsourceid><addsrcrecordid>eNp1kstuEzEUhkcIREthwQugs4RFWt_mVqRKUZQ0rSJ1U1YIWR7PceNqZhzsmVbd5RGQ2MDTIeVJcJJSwYKVjzzf-fxr9CfJW0qOKSHsBG-X5pgJIp4lh7TIyxEphHgeZ14Uo7IQ7CB5FcItITSP-MvkgIuSU0HKw-TXxHlvb7CrhxZ6B5v1j6sWtWp7ewfbwVe2AduBXnrXWQ1LVL4Ho2wzeIR72y_BYz1orAFvUffWdWC82g2ncD5ejCfXF5PN-tt8BpUK2NgOo0xtEfQ29FYHUF0N2rUrFS_i_s6qXddju3Je-QfQcc1q1UDvrWrCZv0TPk8HD5cw3-WZxTzACCMfKT1lNCOb9XdGc_rldfLCxAV883geJZ9m0-vJfLS4Or-YjBcjzRgRIyzTkmeco9E85cyY-OfSjDNWMUNMVgtdYpqLLK2JzvNam6o2rExJkadVxUnGj5KzvXc1VC3WGrveq0auvG1jfumUlf9-6exS3rg7WZKUUCqi4P2jwLuvA4ZetjZobBrVoRuCZBllvMipoBH9sEe1dyF4NE_PUCK3hZDbQshtISL77u9cT-SfBkTgZA_c2wYf_m-S08v5bKf8DSsLxoA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2612387141</pqid></control><display><type>article</type><title>Corrigendum to ‘Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC‐HF baseline characteristics and comparison with contemporary clinical trials’ [Eur J Heart Fail 2020;11:2160–2171]</title><source>Wiley Online Library Free Content</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><identifier>ISSN: 1388-9842</identifier><identifier>EISSN: 1879-0844</identifier><identifier>DOI: 10.1002/ejhf.2404</identifier><identifier>PMID: 34931409</identifier><language>eng</language><publisher>Oxford, UK: John Wiley & Sons, Ltd</publisher><subject>Corrigendum</subject><ispartof>European journal of heart failure, 2022-03, Vol.24 (3), p.591-591</ispartof><rights>2021 European Society of Cardiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fejhf.2404$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fejhf.2404$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,315,781,785,886,1418,1434,27929,27930,45579,45580,46414,46838</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34931409$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><title>Corrigendum to ‘Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC‐HF baseline characteristics and comparison with contemporary clinical trials’ [Eur J Heart Fail 2020;11:2160–2171]</title><title>European journal of heart failure</title><addtitle>Eur J Heart Fail</addtitle><subject>Corrigendum</subject><issn>1388-9842</issn><issn>1879-0844</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp1kstuEzEUhkcIREthwQugs4RFWt_mVqRKUZQ0rSJ1U1YIWR7PceNqZhzsmVbd5RGQ2MDTIeVJcJJSwYKVjzzf-fxr9CfJW0qOKSHsBG-X5pgJIp4lh7TIyxEphHgeZ14Uo7IQ7CB5FcItITSP-MvkgIuSU0HKw-TXxHlvb7CrhxZ6B5v1j6sWtWp7ewfbwVe2AduBXnrXWQ1LVL4Ho2wzeIR72y_BYz1orAFvUffWdWC82g2ncD5ejCfXF5PN-tt8BpUK2NgOo0xtEfQ29FYHUF0N2rUrFS_i_s6qXddju3Je-QfQcc1q1UDvrWrCZv0TPk8HD5cw3-WZxTzACCMfKT1lNCOb9XdGc_rldfLCxAV883geJZ9m0-vJfLS4Or-YjBcjzRgRIyzTkmeco9E85cyY-OfSjDNWMUNMVgtdYpqLLK2JzvNam6o2rExJkadVxUnGj5KzvXc1VC3WGrveq0auvG1jfumUlf9-6exS3rg7WZKUUCqi4P2jwLuvA4ZetjZobBrVoRuCZBllvMipoBH9sEe1dyF4NE_PUCK3hZDbQshtISL77u9cT-SfBkTgZA_c2wYf_m-S08v5bKf8DSsLxoA</recordid><startdate>202203</startdate><enddate>202203</enddate><general>John Wiley & Sons, Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>202203</creationdate><title>Corrigendum to ‘Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC‐HF baseline characteristics and comparison with contemporary clinical trials’ [Eur J Heart Fail 2020;11:2160–2171]</title></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2204-e9593633efc3532ff38856322b2f0f6d4c9e57465d0c77dcfbdf2950875bb3063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Corrigendum</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>European journal of heart failure</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Corrigendum to ‘Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC‐HF baseline characteristics and comparison with contemporary clinical trials’ [Eur J Heart Fail 2020;11:2160–2171]</atitle><jtitle>European journal of heart failure</jtitle><addtitle>Eur J Heart Fail</addtitle><date>2022-03</date><risdate>2022</risdate><volume>24</volume><issue>3</issue><spage>591</spage><epage>591</epage><pages>591-591</pages><issn>1388-9842</issn><eissn>1879-0844</eissn><cop>Oxford, UK</cop><pub>John Wiley & Sons, Ltd</pub><pmid>34931409</pmid><doi>10.1002/ejhf.2404</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1388-9842 |
ispartof | European journal of heart failure, 2022-03, Vol.24 (3), p.591-591 |
issn | 1388-9842 1879-0844 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9050114 |
source | Wiley Online Library Free Content; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals |
subjects | Corrigendum |
title | Corrigendum to ‘Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC‐HF baseline characteristics and comparison with contemporary clinical trials’ [Eur J Heart Fail 2020;11:2160–2171] |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T02%3A41%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Corrigendum%20to%20%E2%80%98Omecamtiv%20mecarbil%20in%20chronic%20heart%20failure%20with%20reduced%20ejection%20fraction:%20GALACTIC%E2%80%90HF%20baseline%20characteristics%20and%20comparison%20with%20contemporary%20clinical%20trials%E2%80%99%20%5BEur%20J%20Heart%20Fail%202020;11:2160%E2%80%932171%5D&rft.jtitle=European%20journal%20of%20heart%20failure&rft.date=2022-03&rft.volume=24&rft.issue=3&rft.spage=591&rft.epage=591&rft.pages=591-591&rft.issn=1388-9842&rft.eissn=1879-0844&rft_id=info:doi/10.1002/ejhf.2404&rft_dat=%3Cproquest_pubme%3E2612387141%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2612387141&rft_id=info:pmid/34931409&rfr_iscdi=true |